Table 2 Coefficient of change in eGFR per year in the two years following initiation of systemic therapy (average change in eGFR per year and for specific patient groups per year).
Patient group | Coefficient of eGFR change per year (mL/min/1.73m2) | 95% CI: lower | 95% CI: upper | p-value |
|---|---|---|---|---|
Whole cohort (unadjusted) | +1.03 | −1.64 | +3.70 | 0.23 |
Nephrectomy prior to systemic therapy | +2.30 | −1.66 | +6.26 | 0.52 |
Metastatic cancer at the point of diagnosis | −0.18 | −5.25 | +4.89 | 0.648 |
Average eGFR < 60 prior to systemic therapy | −1.02 | −6.55 | +4.50 | 0.473 |
